OCRFA recently welcomed four new members to the Scientific Advisory Committee (SAC), our world-class group of leaders in the ovarian cancer field who review and approve all OCRFA research grants. Ronald Alvarez, MD, MBA, of Vanderbilt University Medical Center, Deborah Armstrong, MD, of Johns Hopkins School of Medicine, Robert Coleman, MD, of M.D. Anderson Cancer … Continued
(Nov. 3, 2016) Senescence is the state when normal, healthy cells no longer have the ability to divide, which can occur during chemotherapy or when cancer genes within that cell are activated. Senescence can be very useful, for example, when one wants to stop cancer cells from rapidly dividing, but there can be negative side … Continued
(October 31, 2016) Estrogen signaling is a known factor in how certain estrogen receptive (ER positive) tumors grow in breast and ovarian cancers. That signaling, which can promote malignant tumor growth, can sometimes be effectively treated with anti-estrogen therapy, such as tamoxifen. What is less understood, and currently being studied at the Wistar Institute, is … Continued
We’re excited to announce that OCRFA’s new and refreshed website is live. The new site is reflective of the merger of Ovarian Cancer Research Fund and the Ovarian Cancer National Alliance to become Ovarian Cancer Research Alliance or OCRFA, the largest and oldest non-profit organization dedicated to advancing cancer research, while supporting women and their … Continued
On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated. The FDA states, “despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a … Continued
Meet a Researcher: We had the chance to interview Hui Shen, PhD, a 2016 Liz Tilberis Early Career Award grantee to get to know her! Read our interview here. OCRFA: Tell us about yourself. Dr. Hui Shen: My name is Hui Shen. I am originally from China, and had lived in Hong Kong and Los … Continued
OCRFA and Dr. Elizabeth Swisher spoke about the exciting progress being made by the Stand Up to Cancer Ovarian Cancer Dream Team! The SU2C Ovarian Cancer Dream Team, funded by OCRFA and NOCC, got to work on year ago. Dr. Swisher, a gynecologic oncologist at the University of Washington and co-leader of the Dream Team, … Continued
Miss USA, Deshauna Barber, joined Chad Ramsey and Lisa Mauti on Capitol Hill to meet with Members of Congress to educate them about ovarian cancer. Deshauna spoke with Members about Oral Chemotherapy Parity, asked for more research and awareness, and let them know just how important our community is.
Reps. Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to speak at briefing on the state of ovarian cancer in the United States Watch the Briefing WASHINGTON, D.C. — Today, Reps. Sean Duffy and Rosa DeLauro, both of whom had personal experiences with ovarian cancer, will celebrate the first anniversary of the Congressional Ovarian Cancer Caucus … Continued
(October 5, 2016) A team of researchers, including senior author and former OCRFA grantee Rugang Zhang, PhD, have been studying the relationship between PD-1 and PD-L1, a protein and an accompanying molecule, and t-cells, which are a body’s natural defense against tumor growth. PD-L1 can be found on both cancer cells and healthy cells but, … Continued
We are so excited to announce that Kiehl’s will be donating $25,000 to OCRFA during September. We are thankful for their continued support of the ovarian cancer community and commitment to change the future of ovarian cancer! #30DaysofTeal Visit Kiehl’s LifeRide for OCRFA in Los Angeles! for event details.
Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report, check out a poster on Beyond RECIST 1.1 and a poster on MAGENTA-Making Genetic Testing More Accessible.
Get email updates about research news, action alerts, and ways to join the fight.
